Virios Therapeutics, Inc. (VIRI)

NASDAQ: VIRI · IEX Real-Time Price · USD

0.234

+0.012 (5.41%)

At close: Jul 2, 2024, 4:00 PM

0.237

+0.003 (1.28%)

After-hours: Jul 2, 2024, 7:56 PM EDT

Virios Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Selling, General & Admin	3.72	4.25	4.85	9.81	1.38	Upgrade
Research & Development	1.73	8.07	10.8	0.19	0.8	Upgrade
Operating Expenses	5.45	12.32	15.64	10.01	2.18	Upgrade
Operating Income	-5.45	-12.32	-15.64	-10.01	-2.18	Upgrade
Interest Expense / Income	0	0	0	0.38	0.3	Upgrade
Other Expense / Income	-0.15	-0.07	0.32	-0.04	-	Upgrade
Pretax Income	-5.3	-12.25	-15.96	-10.35	-2.47	Upgrade
Net Income	-5.3	-12.25	-15.96	-10.35	-2.47	Upgrade
Shares Outstanding (Basic)	19	11	8	5	5	Upgrade
Shares Outstanding (Diluted)	19	11	8	5	5	Upgrade
Shares Change	69.62%	32.91%	69.05%	1.96%	-	Upgrade
EPS (Basic)	-0.28	-1.11	-1.92	-2.10	-0.51	Upgrade
EPS (Diluted)	-0.28	-1.11	-1.92	-2.10	-0.51	Upgrade
Free Cash Flow	-4.87	-11.47	-15.69	-3.9	-2.09	Upgrade
Free Cash Flow Per Share	-0.26	-1.04	-1.88	-0.79	-0.43	Upgrade
EBITDA	-5.3	-12.25	-15.96	-9.96	-2.18	Upgrade
EBIT	-5.3	-12.25	-15.96	-9.96	-2.18	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).